MTOR and cholangiocarcinoma: Nevertheless, we cannot exclude that activation of the PI3K/AKT/mTOR cascade influences liver cell fate as well, since we have previously shown that overexpression of myristylated/activated AKT1 in the mouse liver leads to the development of both HCC and CCA [23].